Study Stopped
Lack of funding
Feasibility of Heart Rate Variability Biofeedback With In-patient Pregnant Women
1 other identifier
interventional
10
1 country
1
Brief Summary
Purpose: The investigators plan a feasibility study on an easily disseminated biofeedback tool to reduce stress among hospitalized and expecting mothers. Converging evident suggests that Heart Rate Variability Biofeedback (HRVB) can improve the threshold of stress management and improve executive functioning. Additionally HRVB has been shown to significantly reduce anxiety features in women suffering from perinatal depression. The investigators hypothesize that HRVB will reduce stress levels among expecting mothers hospitalized for pregnancy complications, who are at high risk for depression and anxiety. Participants: Expecting mothers hospitalized for pregnancy complication, who are at high risk for depression and anxiety. Procedures: The investigators plain to use a heart rate variability biofeedback tool to measure stress reduction in hospitalized expectant mothers. This tool will be coupled with validated surveys and scales, high frequency heart rate variability, saliva samples, and qualitative interviews to quantify the reduction in stress from the HRVB tool.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2014
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 16, 2014
CompletedFirst Posted
Study publicly available on registry
April 22, 2014
CompletedStudy Start
First participant enrolled
May 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2016
CompletedResults Posted
Study results publicly available
March 19, 2018
CompletedMarch 19, 2018
May 1, 2017
2 years
April 16, 2014
May 1, 2017
August 25, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility of Using HRVB Among Hospitalized Pregnant Women
The investigators will report rates of enrollment among women approached to join the study, rates of longitudinal data collection, and loss to follow-up.
Baseline, in-patient follow-up (5 to 7 days after baseline), and follow-up phone call (6 to 8 weeks post in-patient follow-up)
Secondary Outcomes (5)
Change in State-Trait Anxiety Inventory From Baseline to In-patient Follow up (5-7 Days).
Baseline to in-patient follow-up (5 to 7 days in between)
Association Between HRVB and High-Frequency Heart Rate Variability (HF-HRV)
Baseline to in-patient follow-up (5 to 7 days in between)
Correlation of HRVB Feedback With Varying Levels of Clinical Depression and Anxiety
Baseline to in-patient follow-up (5 to 7 days in between)
Change in Linear Analog Self-Assessment (LASA) From Baseline to In-patient Follow up (5-7 Days).
Baseline to in-patient follow-up (5 to 7 days in between)
Change in Warwick Edinburgh Mental Well Being Scale From Baseline to In-patient Follow up (5-7 Days).
Baseline to in-patient follow-up (5 to 7 days in between)
Study Arms (1)
Heart Rate Variability Biofeedback Tool
EXPERIMENTALIntervention: Participants will be taught how to use the Heart Rate Variability Biofeedback tool (emWave 2) as a mechanism to reduce stress and anxiety, then use the tool, coupled with deep breathing exercises, to visualize their stress reduction.
Interventions
The Heart Rate Variability Biofeedback tool (emWave 2) will capture heart rate variability (HRV) before and after deep breathing exercises are used among participants. Participants will be able to visualize changes in their HRV and then fill-out self-reported anxiety measures to determine if the breathing exercises and visualization of HRV affected anxiety.
Eligibility Criteria
You may qualify if:
- Patient has signed the informed consent before any study specific procedures are performed.
- Patient is a pregnant female over 18 years of age that is an in-patient on the UNC Women's Hospital antepartum floor.
- Patient agrees to adhere to study requirements
You may not qualify if:
- Does not speak English.
- Patient is not expected be on the antepartum floor of UNC Women's Hospital for at least 7 days.
- Patient's healthcare provider does not want the patient to participate for medical safety purposes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UNC-Chapel Hill
Chapel Hill, North Carolina, 27510, United States
Related Publications (4)
Beckham AJ, Greene TB, Meltzer-Brody S. A pilot study of heart rate variability biofeedback therapy in the treatment of perinatal depression on a specialized perinatal psychiatry inpatient unit. Arch Womens Ment Health. 2013 Feb;16(1):59-65. doi: 10.1007/s00737-012-0318-7. Epub 2012 Nov 25.
PMID: 23179141RESULTBrandon AR, Trivedi MH, Hynan LS, Miltenberger PD, Labat DB, Rifkin JB, Stringer CA. Prenatal depression in women hospitalized for obstetric risk. J Clin Psychiatry. 2008 Apr;69(4):635-43. doi: 10.4088/jcp.v69n0417.
PMID: 18312059RESULTMacMullen N, Dulski LA, Pappalardo B. Antepartum vulnerability: stress, coping, and a patient support group. J Perinat Neonatal Nurs. 1992 Dec;6(3):15-25. doi: 10.1097/00005237-199212000-00004. No abstract available.
PMID: 1295961RESULTPoehlmann J, Fiese BH. The interaction of maternal and infant vulnerabilities on developing attachment relationships. Dev Psychopathol. 2001 Winter;13(1):1-11. doi: 10.1017/s0954579401001018.
PMID: 11346045RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Holly Krohn
- Organization
- UNC Chapel Hill
Study Officials
- PRINCIPAL INVESTIGATOR
Samantha Meltzer-Brody, MD, MPH
UNC-Chapel Hill
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 16, 2014
First Posted
April 22, 2014
Study Start
May 1, 2014
Primary Completion
May 1, 2016
Study Completion
October 1, 2016
Last Updated
March 19, 2018
Results First Posted
March 19, 2018
Record last verified: 2017-05
Data Sharing
- IPD Sharing
- Will not share